Next Article in Journal
Lights and Shadows in Immuno-Oncology Drug Development
Next Article in Special Issue
Retargeting of NK-92 Cells against High-Risk Rhabdomyosarcomas by Means of an ERBB2 (HER2/Neu)-Specific Chimeric Antigen Receptor
Previous Article in Journal
Efficacy of Afatinib in the Treatment of Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
 
 
Editorial

Article Versions Notes

Cancers 2021, 13(4), 690; https://doi.org/10.3390/cancers13040690
Action Date Notes Link
article xml file uploaded 9 February 2021 06:05 CET Original file -
article xml uploaded. 9 February 2021 06:05 CET Update -
article pdf uploaded. 9 February 2021 06:05 CET Version of Record -
article html file updated 9 February 2021 06:06 CET Original file -
article xml file uploaded 9 February 2021 07:17 CET Update -
article xml uploaded. 9 February 2021 07:17 CET Update https://www.mdpi.com/2072-6694/13/4/690/xml
article pdf uploaded. 9 February 2021 07:17 CET Updated version of record https://www.mdpi.com/2072-6694/13/4/690/pdf
article html file updated 9 February 2021 07:18 CET Update -
article html file updated 24 July 2022 20:41 CEST Update https://www.mdpi.com/2072-6694/13/4/690/html
Back to TopTop